PATENT CLAIM ANALYSIS

Application Number: 15742093
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
Aspects of the invention relate to methods for treating ALS comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding superoxide dismutase 1 (SOD1).

Claim (Index 22):
The method of any one of  claims 17  to  20 , wherein the sense strand of the isolated double stranded nucleic acid molecule comprises SEQ ID NO: 4, SEQ ID NO: 34, or SEQ ID NO: 126, and the guide strand of the isolated double stranded nucleic acid molecule comprises SEQ ID NO: 63 or SEQ ID NO: 93.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 86.0
- Lexical Diversity: 1.13889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13636755', '13636728', '14729006', '15099481', '14728653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8601796696078349
- 35 USC 102 Novelty (BERT): 0.6151797743842593
- Combined Prediction Score: 0.8356796800854773
- Mean Citation Score: 498.6139359999999
- Max Citation Score: 534.2475
- Similarity Product: 357.3430021101236

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test